TAM
Tocqueville Asset Management’s Novo Nordisk NVO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-52,127
| Closed | -$4.48M | – | 543 |
|
2024
Q4 | $4.48M | Sell |
52,127
-40,149
| -44% | -$3.45M | 0.07% | 194 |
|
2024
Q3 | $11M | Sell |
92,276
-2,056
| -2% | -$245K | 0.17% | 133 |
|
2024
Q2 | $13.5M | Sell |
94,332
-10,115
| -10% | -$1.44M | 0.22% | 112 |
|
2024
Q1 | $13.4M | Sell |
104,447
-251
| -0.2% | -$32.2K | 0.22% | 114 |
|
2023
Q4 | $10.8M | Buy |
104,698
+102,128
| +3,974% | +$10.6M | 0.2% | 123 |
|
2023
Q3 | $234K | Buy |
2,570
+1,285
| +100% | – | ﹤0.01% | 471 |
|
2023
Q2 | $208K | Hold |
1,285
| – | – | ﹤0.01% | 503 |
|
2023
Q1 | $204K | Buy |
+1,285
| New | +$204K | ﹤0.01% | 502 |
|
2020
Q2 | – | Sell |
-3,935
| Closed | -$237K | – | 672 |
|
2020
Q1 | $237K | Buy |
+3,935
| New | +$237K | 0.01% | 572 |
|
2014
Q3 | – | Sell |
-2,850
| Closed | -$132K | – | 1136 |
|
2014
Q2 | $132K | Buy |
+2,850
| New | +$132K | ﹤0.01% | 1082 |
|